J., & Drucker, D
Factors such as current weight, age, health status, activity level, and consistency with treatment and follow-up can all influence your individual weight loss experience
GLP-1 pills are for adults aiming to lose weight or to improve their blood sugar regulation and management
Eligibility typically requires a BMI of 30 or higher, or 27+ with weight-related health conditions
In a phase 2 clinical trial for obesity, 26 weeks of efinopegdutide (doses 5 to 10mg) resulted in up to 11.8% WL in people with obesity (without diabetes) compared to 7.5% WL with liraglutide 3 mg and 1.8% WL with placebo [77, 78]
But lowering doses too much may reduce effectiveness, says Pinto, adding there needs to be a steady concentration of GLP-1s in the bloodstream for them to work